3B Blackbio Dx Limited 3BBLACKBIOshare price and chart
3B Blackbio Dx closed at ₹1,316.60 on 19 November 2026, down 0.38% on the day. The range since listing is ₹1,085.00 to ₹1,740.00.
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on 3BBLACKBIO
Real prices, every charge counted. Pick one or write your own.Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 19 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Against its sectorWhere this company ranks among similar companies on each measure.
Healthcare Service Provider · 15 peers · mediansWhat the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 13 Nov 2026), sales rose 42.4% from a year earlier to ₹48.3 cr and profit rose 19.8% to ₹18.0 cr.
Nothing in the filings we hold crosses one of our rules yet. Each rule needs a few complete years of results, so recently listed companies often show nothing here.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Share price reaction to resultsWhat the share price did around each recent quarterly result.
Over the last 3 results, the share rose on 1 and fell on 2, and moved by 3% or more on 2.
Q2 FY27: results filed 13 Nov 2026. The share went from its close on 12 Nov 2026 to its close on 16 Nov 2026 +1.93%.
Dividend historyCash the company has paid per share, year by year.
2026 has paid ₹5.00 per share, about ₹380 on ₹1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Healthcare Service Provider. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Revenue and profit, year by yearSales and net profit by financial year or by quarter.
Sales and net profitWhere every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.
FY26In FY26, of every ₹100 of sales it kept ₹42.2 as profit. Other income added ₹18.0.
How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.
Compounded a yearHealth check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY25 | FY26 |
|---|---|---|
| Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax. | 51.9% | 40.0% |
| Net marginOf every ₹100 of sales in the year, how much was left as profit after everything. | 49.4% | 42.2% |
| Interest coverHow many times the company's profit before interest could pay its interest bill. | 641x | 386x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Healthcare Service Provider| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| LALPATHLAB Dr. Lal Path Labs Ltd. | 32,952 cr | 56.2x | 12.0x | 21.5% | 29.1% | 0.00 | 19.4% | +19.6% | 0.89% |
| VIJAYA Vijaya Diagnostic Centre Limited | 15,559 cr | 76.3x | 14.7x | 19.7% | 30.3% | 0.00 | 22.4% | +26.7% | 0.13% |
| METROPOLIS Metropolis Healthcare Limited | 11,587 cr | 51.6x | 7.1x | 13.4% | 19.6% | 0.01 | 12.7% | +15.8% | 0.36% |
| THYROCARE Thyrocare Technologies Limited | 8,035 cr | 56.1x | 14.5x | 28.7% | 37.8% | 0.00 | 15.4% | +25.1% | 1.39% |
| NEPHROPLUS Nephrocare Health Services Limited | 6,455 cr | 49.4x | 5.4x | 6.9% | 13.4% | 0.07 | 11.5% | - | 0.00% |
| SURAKSHA Suraksha Diagnostic Limited | 1,718 cr | 41.1x | 6.2x | 13.8% | 24.8% | 0.02 | 11.9% | +25.8% | 0.15% |
| KRSNAA Krsnaa Diagnostics Limited | 1,673 cr | 17.0x | 1.6x | 10.9% | 12.7% | 0.57 | 11.1% | +31.5% | 0.39% |
| 3BBLACKBIO 3B Blackbio Dx Limited | 1,130 cr | 19.1x | - | - | - | - | 35.4% | +42.4% | 0.38% |
| HEALTHX Health X Platform Limited | 867 cr | - | 1.4x | -0.2% | - | 0.04 | -1.4% | +60.7% | 0.00% |
| CREDENT Credent Connect N Care Limited | 860 cr | - | 6.1x | - | - | 0.15 | - | - | 0.00% |
| ONEGLOBAL One Global Service Provider Limited | 749 cr | 12.0x | - | - | - | - | 14.1% | -50.8% | 0.26% |
| GAUDIUMIVF Gaudium IVF and Women Health Limited | 724 cr | 28.7x | 4.4x | 16.1% | 20.4% | 0.03 | 20.8% | - | 0.00% |
| CHANDAN Chandan Healthcare Limited | 599 cr | - | 3.5x | - | 22.4% | 0.32 | - | - | 0.00% |
| PRAMODINI Pramodini Medicare Limited | 230 cr | - | 2.0x | - | - | 0.26 | - | - | 0.00% |
| INVICTA Invicta Diagnostic Limited | 97 cr | - | 1.7x | - | - | 0.02 | - | - | 0.00% |
| NIDAN Nidan Laboratories and Healthcare Limited | 18 cr | 14.8x | 0.3x | - | 5.5% | 0.17 | 4.8% | -8.4% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Month by month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | · | · | · | · | +3.5 | -5.8 | +6.7 | +16.1 | +18.1 | -24.3 | +1.6 | · | +9.8% 7m |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
No bulk or block deals on record for 3BBLACKBIO in the window we hold.
Read enough? Test 3BBLACKBIO. “Buy 3BBLACKBIO when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free